Your browser doesn't support javascript.
loading
A comprehensive review of the current evidence for trabectedin in advanced myxoid liposarcoma.
Assi, Tarek; Kattan, Joseph; El Rassy, Elie; Honore, Charles; Dumont, Sarah; Mir, Olivier; Le Cesne, Axel.
Afiliación
  • Assi T; Department of Medical Oncology, Gustave Roussy Institut, Villejuif, France; Department of Oncology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Lebanon. Electronic address: tarek.assi@gustaveroussy.fr.
  • Kattan J; Department of Oncology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Lebanon.
  • El Rassy E; Department of Oncology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Lebanon.
  • Honore C; Department of Medical Oncology, Gustave Roussy Institut, Villejuif, France.
  • Dumont S; Department of Medical Oncology, Gustave Roussy Institut, Villejuif, France.
  • Mir O; Department of Medical Oncology, Gustave Roussy Institut, Villejuif, France.
  • Le Cesne A; Department of Medical Oncology, Gustave Roussy Institut, Villejuif, France.
Cancer Treat Rev ; 72: 37-44, 2019 Jan.
Article en En | MEDLINE | ID: mdl-30468937
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Liposarcoma Mixoide / Antineoplásicos Alquilantes / Trabectedina Límite: Humans Idioma: En Revista: Cancer Treat Rev Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Liposarcoma Mixoide / Antineoplásicos Alquilantes / Trabectedina Límite: Humans Idioma: En Revista: Cancer Treat Rev Año: 2019 Tipo del documento: Article